New Drug Application (NDA) for LNZ100 for treatment of presbyopia accepted for review by the U.S. Food and Drug Administration (FDA); PDUFA ...

The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a common age-related condition that causes blurry vision. Local ...

While digital eye strain is highly prevalent for all digital device users and it is recognised that contact lenses can ...